METHODS: Changes of liver coefficient, serum biochemistry, and histopathology were detected after single dose.

Blood glucose levels were determined every week, the effect of single administration was monitored in the first week, and glucose tolerance was determined after three weeks.

In repeated dose decreasing group, the CZP concentration ratio in both brain and serum declined to 0.7 with the dose decrease, almost the same as that of single-dose group.